Evidence map›Paper›PMID 24106671›Full record

ArticleScientia pharmaceutica

Pharmacological analysis of the rat femoral artery response to bradykinin.

Miroslav Radenković, Marko Stojanović, Nebojša Skorupan, Milica Prostran

Open access · goldAbstract read
In one paragraph

Article in Scientia pharmaceutica. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Miroslav RadenkovićDepartment of Pharmacology, Clinical Pharmacology and Toxicology; Faculty of Medicine; University of Belgrade; PO Box 38; 11129 Belgrade; Serbia.
Marko Stojanović
Nebojša Skorupan
Milica Prostran
University of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bradykinin (BK) plays an important role in different physiological processes including the general preservation and modulation of vascular systems. The present study was designed in order to examine the effect of BK on isolated rat femoral artery rings and to investigate the participation of intact endothelium, cyclooxygenase products, Ca(2+) channels, Na(+)/K(+)-ATPase, and B2 kinin receptors in BK-induced action. Circular artery segments were placed in organ baths. The endothelium was mechanically removed from some arteries. Concentration-contraction curves for BK were obtained in the rings previously equilibrated at the basal tone. BK produced a concentration-dependent contraction, which was reduced by endothelial denudation. The BK-induced effect was almost completely inhibited by indomethacin (cyclooxygenase inhibitor) or OKY-046 (thromboxane A2-synthase inhibitor). Nifedipine (Ca(2+) channel blocker), ouabain (Na(+)/K(+)-ATPase inhibitor), or HOE-140 (selective B2 kinin receptor antagonist) significantly reduced the BK-evoked effect. In conclusion, it can be proposed that BK produces concentration- and endothelium-dependent contractions of the isolated rat femoral artery, which is for the most part a consequence of B2 kinin receptor activation. Cyclooxygenase contractile products, especially thromboxane A2, play a significant role in this course of action. The transduction mechanism involved in the process of BK-induced femoral artery contraction include the activation of voltage-gated Ca(2+) channels, and in a smaller extent Na(+)/K(+)-ATPase as well.

Indexed as

BradykininCa2+ channelsEndotheliumFemoral arteryThromboxane A2Introduction

Identifiers

PMID24106671
PMCPMC3791937
OpenAlexW2024966196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.